MjLink Cannabis Business News and Press

1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF) has announced the launch of a new hemp-specific line of Canna Hemp products made with organic hemp seed oil. 

The suite of wellness products include creams, balms, tinctures, lotions, capsules and more, all formulated with its proprietary TerpFX blend of cannabis terpenes, which mimics the profile of cannabis strains without any of the “high” produced by THC.

"Many of our consumers want hemp-specific products and we have delivered a line that appeals to a wide audience,” 1933 Industries president Gene Ruiz said in a statement. “The Canna Hemp wellness line has grown since its inception in 2016 to become a brand that people can trust because of the effectiveness of each formulation, the safety and quality of our ingredients, and the care we put into developing each and every product."

READ: 1933 Industries names Paul Rosen as interim CEO and Eugene Ruiz as president

Select products from the Canna Hemp line are available online through Amazon, Walmart, eBay, Rakuten, and elsewhere.

1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF) announced Monday the appointments of Paul Rosen as its interim CEO and Eugene Ruiz as its president to guide the vertically integrated cannabis consumer packaged goods company’s strategic direction into a new phase of development.

In a statement, the company noted that Rosen is a successful entrepreneur and a pioneer in the global cannabis industry, having founded, led and invested in multiple companies over the past decade. 

Rosen co-founded PharmaCan Capital Corp (NASDAQ:CRON) (TSE:CRON) and served as its first president and CEO. He also has held board positions with a number of publicly traded cannabis companies and currently serves as the executive chairman of Global Go, a consultancy focused on the global regulated cannabis industry. 

READ: 1933 Industries seeing progress on reducing production costs and improving margins as it posts 2Q numbers

He is also a significant shareholder in 1933 Industries, as a result of his private placement investment in the company in March 2019.

AgraFlora Organics International Inc (CSE:AGRA) (OCTMKTS:AGFAF) told investors that its greenhouse in Delta, British Columbia has started commercial cannabis growing and sales are expected to begin this year.

The group's asset Propagation Services Canada Inc (PSC) has begun cultivation using a portfolio of live-plant genetics, focused on producing high potency cannabis with attractive strains at a low cost, AgraFlora said.

READ: AgraFlora Organics subsidiary Farmako signs three-year supply agreement with Zenabis Global's ZenPharm

"Our partners at PSC have a long history of low-cost agricultural production which we expect to translate into our ability to produce low-cost cannabis at the Delta Facility," Brandon Boddy, AgraFlora's chief executive said in a statement.

"We have witnessed a trend in the market towards higher potency genetics with exotic strains on one hand, and a move towards value pricing on the other; but we have yet to see companies successfully do both.

Benchmark Metals Inc (CVE:BNCH) (OTCQB:CYRTF) is set to drill the largest drill program in the Toodoggone region of British Columbia in 2020. The Edmonton-based company is planning a drill program of up to 50,000 metres at the at the Lawyers gold-silver project, which is located in British Columbia’s prolific Golden Triangle mining district. Toodoggone is a historically underexplored area, but it did see production in the form of the Cheni gold-silver mine that operated from 1989 to 1992 and recorded output of 171,200 ounces of gold and 3.6 million ounces of silver.

Tinka Resources Limited (CVE:TK) (OTCPINK:TKRFF) is reactivating its exploration program at its Ayawilca property in Peru after the country’s government lifted restrictions in place as part of the coronavirus pandemic. Last week the Peruvian government initiated Phase 2 of its economic reactivation plan, which includes mineral activities. Vancouver-based Tinka submitted a coronavirus health and monitoring protocol to the Ministry of Health, allowing it to recommence exploration at any time, the company said in a statement Tuesday. 

Antibe Therapeutics Inc (CVE:ATE) has reached a bought deal financing agreement worth $25 million to advance its anti-inflammatory drug ATB-346 and others in its pipeline. The Toronto-based company, which develops non-addictive medicines for pain and inflammation, agreed to offer 62.5 million units at a price of $0.40 per unit. Each unit contains one common share and one-third of a share purchase warrant, and whole warrants are exercisable at $0.60 for a period of 24 months.

Marrone Bio Innovations Inc (NASDAQ:MBII) shares jumped Friday after the company announced an exclusive commercial agreement with multinational agribusiness UPL to distribute its REGALIA MAXX Fungicide in South Africa. South Africa is a major producer of wine and table grapes, with more than 120,000 hectares in production. Marrone’s REGALIA MAXX stimulates plants’ ability to fight diseases and has been used in North America to manage botrytis and other grape diseases.

Marrone Bio Innovations Inc (NASDAQ:MBII) shares jumped Friday after the company announced an exclusive commercial agreement with multinational agribusiness UPL to distribute its REGALIA MAXX Fungicide in South Africa. South Africa is a major producer of wine and table grapes, with more than 120,000 hectares in production. Marrone’s REGALIA MAXX stimulates plants’ ability to fight diseases and has been used in North America to manage botrytis and other grape diseases.

Nerds On Site Inc (CSE:NERD) (OTCQB:NOSUF) said Tuesday that it is advancing with its investment AdamNetworks, which has won patents in the US and Europe for its cybercrime-defeating AdamOne feature "Don't Talk To Strangers." Nerds said it has provided about C$1 million in the form of debt over the last four years to establish AdamNetworks. The company postponed interest payments as the technology was under development in exchange for 20% royalty payable to Nerds. And in other company news, Nerds also said its founders have purchased 400,000 company shares while it has launched investor information pages on Facebook and LinkedIn.

FSD Pharma Inc (CSE:HUGE) (NASDAQ:HUGE) has closed a C$10.125 million financing by way of a private placement of 1.5 million shares priced at C$6.75 and an additional 1.5 million warrants exercisable at C$9.65 for a five-year term. The Toronto-based company also granted the placement agents an option to arrange for purchases of up to an additional C$10.125 million of Securities on the terms above for a period of 30 days following the initial closing. Net proceeds are expected to be used for working capital and other general corporate purposes.

Altamira Gold Corp (CVE:ALTA) (OTCPINK:EQTRF) (FSE:T6UP) announced it had sold its Crepori gold project in Para state to a small-scale Brazilian gold miner as it continues to transition to a junior gold producer from an exploration firm. The firm will receive a total of C$500,000 from the sale to Mineracao do Para Ltda (MAP) and retain a 4% net smelter royalty (NSR) following the start of production. "This agreement is an important step in our transition from an exploration company to a junior gold producer and will add to future revenues, further reducing our need to raise capital through dilutive private placements," Altamira's CEO Mike Bennett told investors.

Cannabis One Holdings Inc (CSE:CBIS) (OTCMKTS:CAAOF) announced Tuesday that it has executed a definitive purchase agreement to acquire Colorado-based Cannabis Corp. which will transform the group into a fully-licensed cannabis operator. Cannabis Corp. holds the licenses and cannabis inventory assets of the Fox Street and Kingston cultivation facilities, as well as the award-winning "The Joint" dispensary in Denver, Colorado. The consideration payable to Cannabis Corp shareholders in connection with the transaction will be US$1,800,000 (C$2,500,000) in Class B super voting shares of Cannabis One at a per CBIS super-voting share price of $1.289 (equivalent to $0.1289 per Class A subordinate voting share) equaling 1,938,974 Class B super voting shares of Cannabis One.

Kincora Copper Ltd’s (CVE:KCC) ongoing drilling campaign at the Trundle copper-gold porphyry project in New South Wales, Australia has gone two from two. On May 19, the company revealed that it had intersected multiple mineralised skarn zones in core from the first of its drill holes into Trundle, at the southern Trundle Park skarn-porphyry target. Fast forward three weeks and the core from the second hole has now been received and reviewed. Kincora has put out some further visuals and it too is showing significant mineralisation, this time at the Mordialloc porphyry target. Although the proof will ultimately lie in the assay testing, and it is still early in Kincora’s maiden drill program at Trundle, both holes look very promising.

Canafarma Hemp Products Corp (CSE:CNFA) has revealed it is teaming up with private drugs group PharmOps to develop a bioequivalent drug to Hydroxychloroquine amid the coronavirus (COVID-19) pandemic. In April this year, Canafarma inked a letter of intent to buy PharmOps and its 25,000 square foot nutraceutical manufacturing facility in New Jersey. The hemp product-focused group told investors that as due diligence continues on that acquisition, the pair have also agreed to work together to develop a bioequivalent material to Hydroxychloroquine - a drug, which US President Donald Trump has been an advocate of amid the battle against the virus.

American Manganese Inc (CVE:AMY) (OTCPINK:AMYZF) has reported highly positive news on the development of its recycling pilot plant after engineering work that has increased its processing capacity. In May this year, the firm announced the launch by its contractor Kemetco of optimization tests in a bid to upgrade the plant, which extracts cathode materials, such as lithium, cobalt, nickel, and manganese at battery-grade purity from spent batteries. "As a result of the upgrades, the pilot plant capacity was successfully increased from 64 kg/day to 160 kg/day, without sacrificing the recovery potential of cobalt, lithium, nickel, manganese, and aluminum," American Manganese said in a statement on Tuesday.

Cannabis One Holdings Inc () (OTCMKTS:CAAOF) announced Tuesday that it has executed a definitive purchase agreement to acquire Colorado-based Cannabis Corp. which will transform the group into a fully-licensed cannabis operator.

Cannabis Corp. holds the licenses and cannabis inventory assets of the Fox Street and Kingston cultivation facilities, as well as the award-winning "The Joint" dispensary in Denver, Colorado.

READ: Cannabis One forms JV for production of high purity THCa extract products

The consideration payable to Cannabis Corp shareholders in connection with the transaction will be US$1,800,000 (C$2,500,000) in Class B super voting shares of Cannabis One at a per super-voting share price of $1.289 (equivalent to $0.1289 per Class A subordinate voting share) equaling to 1,938,974 Class B super voting shares of Cannabis One.

AgraFlora Organics International Inc () (OTCPINK:AGFAF) announced Friday that its wholly-owned subsidiary Farmako GmbH has signed a new supply agreement with Zenanbis Global subsidiary ZenPharm Ltd.

The agreement sees ZenPharm supplying EU-GMP quality flower to Farmako to distribute to medical cannabis patients in Germany.

Farmako anticipates distributing 1,500 kilograms of cannabis flower in Germany over a three-year term, with both parties having the option to extend the supply relationship.

READ: AgraFlora Organics subsidiary submits documents to Health Canada for standard processing license at Winnipeg edibles facility

As part of the agreement, Farmako will receive the products in Germany and distribute them nationally under its own brand to its network of German pharmacies and doctors. In addition, Farmako and ZenPharm have agreed to do more collaborative work on additional product formulations, including cannabis oils and other dosage forms.

Asterion Cannabis Inc has announced a brokered private placement to raise up to C$10 million.

In a statement Wednesday, the company said it intends to use the proceeds to finance pre-construct costs for about 40 hectares (99 acres) of cutting-edge greenhouses in Queensland, Australia, to produce high-quality medicinal cannabis. 

Asterion said the money also will help it execute its early revenue strategic plan and list its shares on a recognized stock exchange while providing general working capital.

READ: Asterion Cannabis welcomes Amy Stephenson as chief investment officer

Under the terms of the financing, Vancouver-based Asterion is offering nearly 6.7 million units at C$1.50 per unit.

AgraFlora Organics International Inc () (OTCPK:AGFAF) said its subsidiary, The Edibles and Infusions Corporation (EIC) has submitted its Site Evidence Package to Health Canada for a standard processing license at its edibles manufacturing facility in Winnipeg, Manitoba.

The company currently holds a research and development license that it intends to use to develop and perfect the recipes and formulations for client edibles, increasing customer satisfaction, reducing operational risk, and allowing the company to move into revenue quickly once the standard processing license is obtained.

Although there is no guarantee on licensing timelines, AgraFlora said its management estimates that the first revenue post-licensing will be delivered in the fourth quarter of 2020.

READ: AgraFlora Organics subsidiary strikes extraction partnership with top tier extractor in Quebec

“License permitting, we are confident in our timelines to be able to reach first packaged sales in Q4 of this year,” James Fletcher, one of the founders and the operational manager of EIC said in a statement on Wednesday.

(NYSEAMERICAN:MMX) () said Thursday that Pan American Silver Corp () (TSE:PAAS) will undertake an overnight marketed public offering of 9 million Maverix shares in a transaction led by underwriters Ltd and PI Financial Corp. Pan American currently owns nearly 25.6 million shares of Vancouver-based Maverix and 8.25 million warrants, which it plans to exercise upon closing of the secondary offering to net Maverix proceeds of about US$15.6 million. Once the offering is completed, Pan American will own about 26.8 million shares or 21% of the company. If the underwriters exercise an overallotment option to purchase an additional 15% of shares sold in the secondary offering, Pan American would own nearly 25.5 million shares or 19.9% of Maverix.

Corp () (OTCQX:NUPMF) announced Thursday it has appointed CEO Mark Cruise to its board of directors, effective immediately. Cruise, formerly the COO of the exploration company, assumed the CEO position on April 27 from Dr Rui Feng, who has stayed on as a director. “The breadth and depth of his experience in the mining sector are an ideal fit for New Pacific’s current stage of development,” said Jack Austin, board chairman, in a statement. “We look forward to working with Mark to advance the Silver Sand Project and build value for our shareholders.”

Blockchain Holdings Ltd () announced Thursday that former SAP, Taleo and Monster.com executive Gordon Zeilstra has been appointed as chief revenue officer or its subsidiary TraceSafe Technologies Inc. Zeilstra has over 25 years of experience with startup technology firms and assisted companies in building international profiles as well as sales pipelines. The new TraceSafe executive will be tasked with establishing and scaling the technology company’s global sales team and maintain relationships with government and private enterprises around the world. 

Pressure BioSciences Inc () announced Thursday that its pending merger partner Cannaworx Inc will launch a patented proprietary hemp immune booster supplement by mid-July. Once it hits the market, the company believes this product could be one of very few over-the-counter, FDA-registered hemp supplements products — if not the only one — that can claim to be an immune booster. The product, enhanced with hemp seed oil, increases the number of helper T cells in the body, which boosts immune response by enabling macrophage cells to kill and consume bacteria, viruses and other invaders.

Pressure BioSciences Inc () announced Thursday that its pending merger partner Cannaworx Inc will launch a patented proprietary hemp immune booster supplement by mid-July. Once it hits the market, the company believes this product could be one of very few over-the-counter, FDA-registered hemp supplements products — if not the only one — that can claim to be an immune booster. The product, enhanced with hemp seed oil, increases the number of helper T cells in the body, which boosts immune response by enabling macrophage cells to kill and consume bacteria, viruses and other invaders.

Endeavour Mining Corporation () (OTCQX:EDVMF) reported Thursday that its shareholders have voted “overwhelmingly” in favour of its acquisition of SEMAFO Inc (), announced in March. The C$1 billion deal brings together six mines with strong cash flow into one portfolio, the opportunity to optimize assets, and a growth pipeline to create a leading West Africa-based gold producer generating over 1 million ounces a year. Over 99.9% of Endeavour’s shareholders, or 91.9 million votes, are in favour of the merger, the firm said in a statement. Both of the company’s boards have unanimously approved the transaction.

Exactus Inc () has announced a hemp buyback program to help support farmers who buy seeds from the company and struggle during planting season due to the coronavirus (COVID-19) pandemic. The company said it will purchase back hemp biomass that meets its processing specifications at fair market value from farmers who buy Exactus’ feminized CBD seeds. The group added that it will match every dollar farmers spend on seeds for those who opt into the program. “We understand that farmers have been greatly impacted by COVID-19 and we want to provide an opportunity for them to find relief from any financial hardship they may have occurred during this time,” Exactus President Derek Du Chesne said in a statement.

() has announced the debut of its Rapid Application Programming Interface for Devices (RAPID) mobile solution, which is designed to provide small and midsize businesses (SMBs) with access to the group's Multiscreen-as-a-Service (MaaS) platform. RAPID offers SMBs a pre-integrated software layer on mobile to access many of the features of the company’s broader MaaS platform. With RAPID, businesses can deploy native mobile application portfolios on Apple iOS and Google Android operating systems in just a few weeks, the company said. "A lot of small and midsize businesses in the United States are struggling right now as (coronavirus) COVID-19 forces them to not only reduce their workforces, but also rethink how they engage customers and achieve digital transformation during a pandemic," Phuware's chief technology officer, Luan Dang said in a statement.

() () said that its portfolio asset company Cocoon Technology LLC is helping shape contactless commerce during the coronavirus pandemic via its self-service CocoonPod, which gives customers the option to make payments directly through the kiosk, or a mobile device. “As dispensaries begin the initial phases of reopening, they are required to follow guidelines protecting the health and safety of both employees and customers. CocoonPod mitigates these safety concerns while reducing resource requirements,” the company said in a statement on Thursday. Specifically, the CocoonPod self-service kiosk is equipped with mobile applications, platform agnostic integrations into business management systems and payment providers. The consumer-facing units can function as stand-alone kiosks or multi-unit pods.

Mawson Resources Ltd () (OTCMKTS:MWSNF) has unveiled another round of high-grade drill assays for its giant Rajapalot gold project in Finland and told investors that it is on track to deliver an updated resources estimate at the beginning of the third quarter of this year. The results come from five additional holes at the Palokas prospect, which were sunk during the recent 14.1 kilometre (km) winter program, and include the deepest intersection so far at Palokas, namely, from a hole 449.7 metres (m) deep. That hole hit 4.9 metres at a grade of 18 grams per ton (g/t) gold, 1,236 parts per million (ppm) cobalt, 18.8 g/t gold equivalent (AuEq) from 449.7 metres, which included 2 metres at an impressive 31.2 g/t gold from 452.6m.

 Corporation () (FSE:IP4) revealed Thursday that its wholly-owned subsidiary, InnoCan Pharma Ltd (Innocan Israel) has filed an international patent application for a novel cannabis-based skin treatment for psoriasis, a disorder where skin cells build up and form dry patches. The patent application stakes out a claim for a topical pharmaceutical composition to treat the symptoms of itching and inflammation commonly associated with psoriasis. "The global psoriasis drugs market is forecast to reach $39 billion by 2027,” according to a report by market intelligence and strategic consulting firm Reports and Data.

() (OTCMKTS:XXMMF) has said fieldwork will kick off at the permitted Providence property in the Greenwood mining camp in British Columbia (BC) in June. The crews and equipment needed for exploration drilling and trenching have been mobilized, Ximen said in a statement on Thursday. Ximen said the work includes the implementation of protocols and measures to prevent and control the risk of transmission of coronavirus (COVID-19).

() () said that its portfolio asset company Cocoon Technology LLC is helping shape contactless commerce during the coronavirus pandemic via its self-service CocoonPod, which gives customers the option to make payments directly through the kiosk, or a mobile device.

Companies are shifting to contactless payments as governments and consumers try to minimize the interactions between people to combat the spread of the virus.

“As dispensaries begin the initial phases of reopening, they are required to follow guidelines protecting the health and safety of both employees and customers. CocoonPod mitigates these safety concerns while reducing resource requirements,” the company said in a statement on Thursday.

READ: Australis Capital's Cocoon Technology nears launch of kiosks in one of Nevada's largest cannabis retailers

Cannabis One Holdings Inc () has announced the formation of Diamond Ventures for the production of high purity THCa extract products to further expand its current product offerings beyond existing brands including Honu, Cheech, INDVR and Fat Face Farms.

Diamond Ventures is a new and equally owned joint venture between Cannabis One US Inc, a wholly owned subsidiary of Cannabis One, and Empire, a Colorado limited liability company.

The joint venture will utilize licensed proprietary technology and know-how that allows for the partitioning of acid cannabinoids from their neutral counterparts with high efficiency. 

READ: Cannabis One Holdings raises $1.6 million in management-led strategic financing

This technology will be used in tandem with licensed proprietary techniques to consistently achieve greater than 99% purity THCa "diamonds" for use in a wide array of new retail products.